Literature DB >> 24299311

CD133 positive cells isolated from A549 cell line exhibited high liver metastatic potential.

H Zhang, N Yang, B Sun, Y Jiang, C Hou, C Ji, Y Zhang, Y Liu, P Zuo.   

Abstract

Lung cancer remains a major cause of cancer-related lethality because of high incidence and recurrence in spite of significant advances in staging and therapy. In present study, we identified a subpopulation of cells isolated from the A549 cell line with marker CD133. In vivo results showed that A549 CD133+ cells displayed high liver metastatic potential. Severe liver cell damage with tumor cell invasion revealed by pathological examination and these changes were consistent with the results of serological tests where the plasma GPT and GOT level are significantly higher than that of the control group. Compared with A549 cells, A549 CD133+ cells expressed high levels of VEGF and exhibited high migration and invasion capability. In conclusion, we first reported that A549 CD133+ cells exhibited characteristic of high liver metastatic potential which makes it be a suitable model for further study of liver metastasis of lung adenocarcinoma and provide a potential platform for anti-metastatic drug discovery or evaluation.

Entities:  

Keywords:  human lung adenocarcinoma, liver metastasis, migration, invasion, CD133

Mesh:

Substances:

Year:  2014        PMID: 24299311     DOI: 10.4149/neo_2014_021

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  4 in total

1.  Antagomir-1290 suppresses CD133⁺ cells in non-small cell lung cancer by targeting fyn-related Src family tyrosine kinase.

Authors:  Bo Sun; Nan Yang; Yao Jiang; Huifeng Zhang; Chunying Hou; Chao Ji; Yanyong Liu; Pingping Zuo
Journal:  Tumour Biol       Date:  2015-03-18

2.  MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN.

Authors:  Hongyan Wang; Xiaoying Guan; Yongsheng Tu; Shaoqiu Zheng; Jie Long; Shuhua Li; Cuiling Qi; Xiaobin Xie; Huiqiu Zhang; Yajie Zhang
Journal:  J Exp Clin Cancer Res       Date:  2015-06-11

3.  Potential role of CXCL9 induced by endothelial cells/CD133+ liver cancer cells co-culture system in tumor transendothelial migration.

Authors:  Qiang Ding; Yujia Xia; Shuping Ding; Panpan Lu; Liang Sun; Yuhui Fan; Xin Li; Ying Wang; De-An Tian; Mei Liu
Journal:  Genes Cancer       Date:  2016-07

Review 4.  Is CD133 expression a prognostic biomarker of non-small-cell lung cancer? A systematic review and meta-analysis.

Authors:  Hong Wu; Xiao-wei Qi; Guang-ning Yan; Qing-bi Zhang; Chuan Xu; Xiu-wu Bian
Journal:  PLoS One       Date:  2014-06-18       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.